Organigram loss narrows on brisk cannabis sales
New Brunswick cannabis producer Organigram’s loss narrowed to 1.3 million Canadian dollars ($1 million) as adult-use sales soared…
News January 11
Latest In: Canopy Growth
Analysts cut hundreds of millions from Tilray, Canopy, Aurora marijuana sales forecasts
Analysts have slashed hundreds of millions of dollars off their 2022 sales forecasts for three Canadian cannabis producers,…
News January 5
MJBizDaily’s most-read cannabis business stories of 2021
With an ongoing pandemic, a new president and Congress and five new state cannabis markets worth a collective…
News December 27
How Auxly Cannabis beat ‘bigger’ Canadian rivals in 2021: Q&A with CEO Hugo Alves
Auxly Cannabis gained more share of Canada's recreational marijuana market than any of its competitors in 2021, and…
News December 23
A primer on the secondary sales market for marijuana greenhouses
Experts recommend that cannabis companies looking to make a successful sale of greenhouse facilities on the secondary market…
News December 23
How will inflation impact cannabis retail + two deals that illustrate industry change
While wholesale cannabis prices have been going up - sometimes as much as 30%, according to a recent…
News December 22
German pharma firm Dermapharm buying Canopy’s cannabinoid subsidiary C3
German pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from…
News December 15
Canada under growing pressure to lift medical marijuana import ban
A disparate group of countries, businesses and organizations is calling on the Canadian government to remove nontariff barriers…
News December 9
Constellation CEO Newlands exits board of cannabis producer Canopy
Bill Newlands, CEO of Canopy Growth benefactor Constellation Brands, resigned from the board of directors of the struggling…
News December 2Featured
1
Latest Sponsored
